Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cosmos Health (COSM) Operating Expenses (2016 - 2025)

Cosmos Health's Operating Expenses history spans 13 years, with the latest figure at $13.5 million for Q4 2025.

  • Quarterly results put Operating Expenses at $13.5 million for Q4 2025, up 35.26% from a year ago — trailing twelve months through Dec 2025 was $24.6 million (up 23.89% YoY), and the annual figure for FY2025 was $24.6 million, up 23.89%.
  • Operating Expenses for Q4 2025 was $13.5 million at Cosmos Health, up from $4.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $14.8 million in Q4 2023 to a low of $1.6 million in Q1 2022.
  • The 5-year median for Operating Expenses is $3.5 million (2021), against an average of $4.8 million.
  • The sharpest move saw Operating Expenses surged 182.39% in 2021, then plummeted 43.74% in 2022.
  • Year by year, Operating Expenses stood at $3.5 million in 2021, then soared by 123.63% to $7.7 million in 2022, then skyrocketed by 91.61% to $14.8 million in 2023, then crashed by 32.71% to $10.0 million in 2024, then soared by 35.26% to $13.5 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $13.5 million, $4.4 million, and $3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.